These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20589130)

  • 21. Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.
    Zlobec I; Bihl MP; Schwarb H; Terracciano L; Lugli A
    Int J Cancer; 2010 Jul; 127(2):367-80. PubMed ID: 19908233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microsatellite Instability Is Common in Colorectal Cancer in Native Nigerians.
    Irabor DO; Oluwasola OA; Ogunbiyi OJ; Ogun OG; Okolo CA; Melas M; Gruber SB; Shi C; Raskin L
    Anticancer Res; 2017 May; 37(5):2649-2654. PubMed ID: 28476840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters.
    Hashmi AA; Ali R; Hussain ZF; Faridi N; Khan EY; Bakar SMA; Edhi MM; Khan M
    World J Surg Oncol; 2017 Jun; 15(1):116. PubMed ID: 28651545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.
    Bosari S; Viale G; Bossi P; Maggioni M; Coggi G; Murray JJ; Lee AK
    J Natl Cancer Inst; 1994 May; 86(9):681-7. PubMed ID: 8158699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
    Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
    Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of CD10 and CD15 in colorectal mucinous and signet ring adenocarcinomas and its relation to clinicopathological features and prognosis.
    Foda AAM; Alamer HA; Ikram N; Helali HA; Fayad FS; Hussian SW; Abdelwahab K; Akl T; Emarah Z; Ramez AM
    Cancer Biomark; 2022; 33(1):143-150. PubMed ID: 34487022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinicopathologic study of Ki-67 proliferation index in colorectal carcinoma.
    Ahmed NY; Ismail AT; Kareem TS
    Saudi Med J; 2012 Aug; 33(8):841-5. PubMed ID: 22886115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of functional prolactin and its receptor in human colorectal cancer.
    Otte JM; Otte C; Beckedorf S; Schmitz F; Vonderhaar BK; Fölsch UR; Kloehn S; Herzig KH; Mönig H
    Int J Colorectal Dis; 2003 Jan; 18(1):86-94. PubMed ID: 12458387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low frequency of p53 gene mutation and protein expression in mucinous colorectal carcinomas.
    Hanski C; Tiecke F; Hummel M; Hanski ML; Ogorek D; Rolfs A; Schmitt-Gräff A; Stein H; Riecken EO
    Cancer Lett; 1996 Jun; 103(2):163-70. PubMed ID: 8635153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical detection of p53 tumor suppressor gene protein in canine epithelial colorectal tumors.
    Wolf JC; Ginn PE; Homer B; Fox LE; Kurzman ID
    Vet Pathol; 1997 Sep; 34(5):394-404. PubMed ID: 9381650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucinous and Signet Ring Cell Differentiation Affect Patterns of Metastasis in Colorectal Carcinoma and Influence Survival.
    Kermanshahi TR; Magge D; Choudry H; Ramalingam L; Zhu B; Pingpank J; Ahrendt S; Holtzman M; Zeh H; Bartlett D; Zureikat A; Pai RK
    Int J Surg Pathol; 2017 Apr; 25(2):108-117. PubMed ID: 27571790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microsatellite instability of each tumor in sporadic synchronous multiple colorectal cancers.
    Abe Y; Masuda H; Okubo R
    Oncol Rep; 2001; 8(2):299-304. PubMed ID: 11182044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MCT4 Expression Is a Potential Therapeutic Target in Colorectal Cancer with Peritoneal Carcinomatosis.
    Kim HK; Lee I; Bang H; Kim HC; Lee WY; Yun SH; Lee J; Lee SJ; Park YS; Kim KM; Kang WK
    Mol Cancer Ther; 2018 Apr; 17(4):838-848. PubMed ID: 29483215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional expression of HGF and its receptor in human colorectal cancer.
    Otte JM; Schmitz F; Kiehne K; Stechele HU; Banasiewicz T; Krokowicz P; Nakamura T; Fölsch UR; Herzig K
    Digestion; 2000; 61(4):237-46. PubMed ID: 10878450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histopathology analysis of benign colorectal diseases and colorectal cancer in Hatyai Hospital, Songkhla, Thailand.
    Kotepui M; Piwkham D; Songsri A; Charoenkijkajorn L
    Asian Pac J Cancer Prev; 2013; 14(4):2667-71. PubMed ID: 23725193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer.
    Nosho K; Shima K; Irahara N; Kure S; Firestein R; Baba Y; Toyoda S; Chen L; Hazra A; Giovannucci EL; Fuchs CS; Ogino S
    Mod Pathol; 2009 Jul; 22(7):922-32. PubMed ID: 19430421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic value of p73 overexpression in colorectal carcinoma: a clinicopathologic, immunohistochemical, and statistical study of 204 patients.
    Toumi AA; El Hadj Oel A; Ben Mahmoud LK; Ben Hmida Ael M; Chaar I; Gharbi L; Mzabi S; Bouraoui S
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):128-36. PubMed ID: 19956069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 protein accumulation in colorectal cancer tissue has prognostic value only in left-sided colon tumours.
    Paluszkiewicz P; Berbeć H; Pawłowska-Wakowicz B; Cybulski M; Paszkowska A
    Cancer Detect Prev; 2004; 28(4):252-9. PubMed ID: 15350628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of Association between an XRCC1 Gene Polymorphism and Colorectal Cancer Survival in Thailand.
    Siewchaisakul P; Suwanrungruang K; Poomphakwaen K; Wiangnon S; Promthet S
    Asian Pac J Cancer Prev; 2016; 17(4):2055-60. PubMed ID: 27221895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinoma.
    Kim JH; Bae JM; Song YS; Cho NY; Lee HS; Kang GH
    Oncotarget; 2016 Mar; 7(12):13372-87. PubMed ID: 26528695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.